Burgess, J. L., Bernstein, J. N., & Hurlbut, K. (1994). Aldicarb poisoning. A case report with prolonged cholinesterase inhibition and improvement after pralidoxime therapy. Archives of internal medicine, 154(2), 221-4.
Aldicarb is the most potent of the commercially available carbamate pesticides and is an unusual source of acute human poisonings. We present the case of a 43-year-old man exposed to aldicarb who developed severe cholinergic symptoms and progressive weakness requiring intubation for 5 days. Both his red blood cell cholinesterase and plasma pseudocholinesterase levels were depressed for a minimum of 44 hours. He demonstrated neuromuscular improvement concurrent with pralidoxime administration. The pertinent medical literature on aldicarb poisoning is reviewed.
Morrissey, B., Burgess, J. L., & Robertson, W. O. (1995). Washington's experience and recommendations re: Anticoagulant rodenticides. Veterinary and Human Toxicology, 37(4), 362-363.
Burgess, J. L., & Crutchfield, C. D. (1995). Tucson fire fighter exposure to products of combustion: A risk assessment. Applied Occupational and Environmental Hygiene, 10(1), 37-42.
Anthony, T. R., Joggerst, P., James, L., Burgess, J. L., Leonard, S. S., & Shogren, E. S. (2007). Method development study for APR cartridge evaluation in fire overhaul exposures. Annals of Occupational Hygiene, 51(8), 703-716.
Burgess, J. L., Kurzius-Spencer, M., O'Rourke, M. K., Littau, S. R., Roberge, J. L., Meza-Montenegro, M. M., Gutiérrez-Millán, L. E., & Harris, R. B. (2013). Environmental arsenic exposure and serum matrix metalloproteinase-9. Journal of Exposure Science and Environmental Epidemiology, 23(2), 163-169.